Lisdexamfetamine 30 MG capsule 100S
Ended Awarded Last action
- Contract number
- SPE2DR26F0A7D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,781
Award facts
- Contract value 100% obligated
- $16,780.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,780.84 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (100-count units) on January 29, 2026, with an ultimate completion date of January 30, 2026. This firm fixed-price, non-set-aside contract is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor that supplies critical medications across multiple therapeutic domains to federal military and healthcare systems through competitively awarded contracts. The company's portfolio with the Defense Logistics Agency includes delivery of specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare institutions. This particular delivery order for Lisdexamfetamine, a medication used in the treatment of attention deficit hyperactivity disorder, continues the company's consistent role as a key pharmaceutical vendor for federal medical procurement needs.
Quick answers
Who was awarded contract SPE2DR26F0A7D?
SPE2DR26F0A7D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F0A7D worth?
The government has obligated $16,781 on SPE2DR26F0A7D.
Is contract SPE2DR26F0A7D an order under another contract?
Yes. SPE2DR26F0A7D is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F0A7D competed?
The extent of competition for SPE2DR26F0A7D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award